Two investigators (PD and BQ) independently extracted data including demographic data, comorbidities, laboratory data and outcome data from all of the included studies using a standardized data collection form for analysis and, all data of the patients were checked by two investigators (PD and LY) independently to verify data accuracy.
The hematological parameters (including red blood cell count, platelet count, hemoglobin, white blood cell, lymphocyte count, neutrophil count, and monocyte count) were determined using XN-9000 Hematology Analyzer (Sysmex, Kobe, Japan). The ADVIA 2400 Clinical Chemistry System (Siemens, Erlangen, Germany) was used to measure the albumin, alanine aminotransferase, aspartate aminotransferase, creatine kinase, creatinine (Cr), lactate dehydrogenase, total bilirubin, and blood urea nitrogen. The levels of cTnI-ultra, CK-MB, MYO, and NT-proBNP was measured on a ADVIA Centaur XP platform (Siemens, Erlangen, Germany). Coagulation parameters including plasma D-dimer and prothrombin time were measured by CA7000 Coagulation Analyzer (Sysmex, Kobe, Japan).
The hematological parameters (including red blood cell count, platelet count, hemoglobin, white blood cell, lymphocyte count, neutrophil count, and monocyte count) were determined using XN-9000 Hematology Analyzer (Sysmex, Kobe, Japan). The ADVIA 2400 Clinical Chemistry System (Siemens, Erlangen, Germany) was used to measure the albumin, alanine aminotransferase, aspartate aminotransferase, creatine kinase, creatinine (Cr), lactate dehydrogenase, total bilirubin, and blood urea nitrogen. The levels of cTnI-ultra, CK-MB, MYO, and NT-proBNP was measured on a ADVIA Centaur XP platform (Siemens, Erlangen, Germany). Coagulation parameters including plasma D-dimer and prothrombin time were measured by CA7000 Coagulation Analyzer (Sysmex, Kobe, Japan).